Komori
Jcu (4975) · RiskMitigated

Risk of price fluctuations and impairment losses on securities held

First written in FY2016. 4 of 8 entries say "Materialised", first in FY2018. Latest entry: FY2025.

8entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2016 – FY2017RestatedFY2019MaterialisedFY2024-Q1 – FY2024-Q32016: 120162017: 120172018: 120182019: 120192020: 020202021: 020212022: 020222023: 220232024: 120242025: 12025
Same theme, other companies
Impairment Risk for Shares Held for Business RelationshipsA theme 6 companies write about · 6 as a headwind · 0 as a tailwind

Jcu moved to the "Worse" side of this theme in 2023, 3 years after the typical company in this theme (2020).

2 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2025MitigatedAnnual report

    「There were no applicable matters for the current consolidated fiscal year (from 1 April 2024 to 31 March 2025).」

    The Company recognized a ¥62.889 million loss on valuation of securities in the previous fiscal year, but states that no impairment losses on securities were recognized during the current fiscal year.
  2. FY2024-Q3MaterialisedAnnual report

    「Loss on valuation of investment securities - ¥663 thousand」

    The Company recognized a ¥663 thousand loss on valuation of investment securities in the cumulative third-quarter period, meaning that the risk of price fluctuations and valuation losses on securities held materialized.
  3. FY2024-Q2MaterialisedAnnual report

    「Loss on valuation of investment securities - ¥656 thousand」

    The Company recognized a ¥656 thousand loss on valuation of investment securities in the cumulative second-quarter period, meaning that the risk of price fluctuations and valuation losses on securities held materialized.
  4. FY2024-Q1MaterialisedAnnual report

    「Loss on valuation of investment securities - ¥647 thousand」

    The Company recognized a ¥647 thousand loss on valuation of investment securities in the first quarter, meaning that the risk of price fluctuations and valuation losses on securities held materialized.
  5. FY2019RestatedAnnual report

    「The Group holds shares to build and maintain relationships with business partners and others. However, if the value of the shares held falls significantly due to a sharp decline in the stock market or deterioration in the performance of an investee company, and recovery is deemed unlikely, the Group will recognize impairment losses on the shares held, which will affect its results.」

    The risk of declines in the price of, and impairment losses on, securities held is reiterated. The disclosure states that no impairment losses on securities were recognized during the fiscal year.
  6. FY2018MaterialisedAnnual report

    「During the fiscal year, impairment losses of ¥182.974 million were recognized on unlisted shares classified as other securities.」

    The risk of declines in the price of, and impairment losses on, securities held materialized, with ¥182.974 million in impairment losses recognized on unlisted shares.
  7. FY2017RestatedAnnual report

    「If the value of the shares held falls significantly due to a sharp decline in the stock market or deterioration in the performance of an investee company, and recovery is deemed unlikely, the Group will recognize impairment losses on the shares held, which will affect its results.」

    The risk of declines in the price of, and impairment losses on, shares held to build and maintain relationships with business partners and others is reiterated.
  8. FY2016First statedAnnual report

    「If the value of the shares held falls significantly due to a sharp decline in the stock market or deterioration in the performance of an investee company, and recovery is deemed unlikely, the Group will recognize impairment losses on the shares held, which will affect its results.」

    The decline in the price of, and impairment losses on, shares held to build and maintain relationships with business partners and others are identified as risks.
Moved together

"Earnings Base Centered on Overseas Pharmaceutical Sales" moved the same way as this thread, in the same document, in 4 of its 8 moves.

42222★12345
  1. ★This thread
  2. 1Earnings Base Centered on Overseas Pharmaceutical Sales4×
  3. 2Demand Fluctuation Risk in the Automobile and Electronics Industries2×
  4. 3Strengthening the Sales Network and Overseas Sales Operations Through Overseas Subsidiaries2×
  5. 4Establishment of a semiconductor-related research and manufacturing site in Kumamoto Prefecture2×
  6. 5Continued losses in the new business2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Jcu's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.